
Sign up to save your podcasts
Or


Plus: The FDA approves a new drug designed to cut the risk of addiction and overdoses related to opioids. And, Apple shares rise in offhours trading after the company’s earnings top expectations. Luke Vargas hosts.
Sign up for WSJ’s free What’s News newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices
By The Wall Street Journal4.2
652652 ratings
Plus: The FDA approves a new drug designed to cut the risk of addiction and overdoses related to opioids. And, Apple shares rise in offhours trading after the company’s earnings top expectations. Luke Vargas hosts.
Sign up for WSJ’s free What’s News newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices

2,851 Listeners

1,713 Listeners

4,420 Listeners

406 Listeners

427 Listeners

1,649 Listeners

1,448 Listeners

1,044 Listeners

1,320 Listeners

6,097 Listeners

1,573 Listeners

212 Listeners

1,322 Listeners

586 Listeners

151 Listeners

87 Listeners

80 Listeners

150 Listeners